BIOMAT Database Logo BIOMAT Database Logo

Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. 1998

S L Rowland-Jones, and T Dong, and K R Fowke, and J Kimani, and P Krausa, and H Newell, and T Blanchard, and K Ariyoshi, and J Oyugi, and E Ngugi, and J Bwayo, and K S MacDonald, and A J McMichael, and F A Plummer
Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, UK. sarah.rowland-jones@ndm.ox.ac.uk

Many people who remain persistently seronegative despite frequent HIV exposure have HIV-specific immune responses. The study of these may provide information about mechanisms of natural protective immunity to HIV-1. We describe the specificity of cytotoxic T lymphocyte responses to HIV in seronegative prostitutes in Nairobi who are apparently resistant to HIV infection. These women have had frequent exposure to a range of African HIV-1 variants, primarily clades A, C, and D, for up to 12 yr without becoming infected. Nearly half of them have CTL directed towards epitopes previously defined for B clade virus, which are largely conserved in the A and D clade sequences. Stronger responses are frequently elicited using the A or D clade version of an epitope to stimulate CTL, suggesting that they were originally primed by exposure to these virus strains. CTL responses have been defined to novel epitopes presented by HLA class I molecules associated with resistance to infection in the cohort, HLA-A*6802 and HLA-B18. Estimates using a modified interferon-gamma Elispot assay indicate a circulating frequency of CTL to individual epitopes of between 1:3,200 and 1:50,000. Thus, HIV-specific immune responses-particularly cross-clade CTL activity- may be responsible for protection against persistent HIV infection in these African women.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D007630 Kenya A republic in eastern Africa, south of ETHIOPIA, west of SOMALIA with TANZANIA to its south, and coastline on the Indian Ocean. Its capital is Nairobi. Republic of Kenya
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011477 Sex Work The act or practice of engaging in sexual relations for money or other benefit. Commercial Sex,Prostitution,Sex Industry,Industries, Sex,Sex Industries,Sex, Commercial,Work, Sex
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D013602 T-Lymphocytes, Cytotoxic Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These CD8-positive cells are distinct from NATURAL KILLER CELLS and NATURAL KILLER T-CELLS. There are two effector phenotypes: TC1 and TC2. Cell-Mediated Lympholytic Cells,Cytotoxic T Cells,Cytotoxic T Lymphocyte,Cytotoxic T-Lymphocytes,TC1 Cell,TC1 Cells,TC2 Cell,TC2 Cells,Cell Mediated Lympholytic Cells,Cell, Cell-Mediated Lympholytic,Cell, TC1,Cell, TC2,Cell-Mediated Lympholytic Cell,Cytotoxic T Cell,Cytotoxic T Lymphocytes,Cytotoxic T-Lymphocyte,Lymphocyte, Cytotoxic T,Lympholytic Cell, Cell-Mediated,Lympholytic Cells, Cell-Mediated,T Cell, Cytotoxic,T Lymphocyte, Cytotoxic,T Lymphocytes, Cytotoxic,T-Lymphocyte, Cytotoxic
D015234 HLA-A Antigens Polymorphic class I human histocompatibility (HLA) surface antigens present on almost all nucleated cells. At least 20 antigens have been identified which are encoded by the A locus of multiple alleles on chromosome 6. They serve as targets for T-cell cytolytic responses and are involved with acceptance or rejection of tissue/organ grafts. Antigens, HLA-A,HLA-A,Antigens, HLA A,HLA A Antigens
D015235 HLA-B Antigens Class I human histocompatibility (HLA) surface antigens encoded by more than 30 detectable alleles on locus B of the HLA complex, the most polymorphic of all the HLA specificities. Several of these antigens (e.g., HLA-B27, -B7, -B8) are strongly associated with predisposition to rheumatoid and other autoimmune disorders. Like other class I HLA determinants, they are involved in the cellular immune reactivity of cytolytic T lymphocytes. Antigens, HLA-B,HLA-B Antigen,HLA-B,Antigen, HLA-B,Antigens, HLA B,HLA B Antigen,HLA B Antigens

Related Publications

S L Rowland-Jones, and T Dong, and K R Fowke, and J Kimani, and P Krausa, and H Newell, and T Blanchard, and K Ariyoshi, and J Oyugi, and E Ngugi, and J Bwayo, and K S MacDonald, and A J McMichael, and F A Plummer
Conserved HIV-1 epitopes continuously elicit subdominant cytotoxic T-lymphocyte responses.
December 2009, The Journal of infectious diseases,
S L Rowland-Jones, and T Dong, and K R Fowke, and J Kimani, and P Krausa, and H Newell, and T Blanchard, and K Ariyoshi, and J Oyugi, and E Ngugi, and J Bwayo, and K S MacDonald, and A J McMichael, and F A Plummer
Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1.
November 2003, Journal of immunology (Baltimore, Md. : 1950),
S L Rowland-Jones, and T Dong, and K R Fowke, and J Kimani, and P Krausa, and H Newell, and T Blanchard, and K Ariyoshi, and J Oyugi, and E Ngugi, and J Bwayo, and K S MacDonald, and A J McMichael, and F A Plummer
Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.
May 2015, Journal of virology,
S L Rowland-Jones, and T Dong, and K R Fowke, and J Kimani, and P Krausa, and H Newell, and T Blanchard, and K Ariyoshi, and J Oyugi, and E Ngugi, and J Bwayo, and K S MacDonald, and A J McMichael, and F A Plummer
Cytotoxic T-cell epitopes in HIV/SIV infection.
January 1993, AIDS (London, England),
S L Rowland-Jones, and T Dong, and K R Fowke, and J Kimani, and P Krausa, and H Newell, and T Blanchard, and K Ariyoshi, and J Oyugi, and E Ngugi, and J Bwayo, and K S MacDonald, and A J McMichael, and F A Plummer
Specificity of CD8+ T-Cell Responses Following Vaccination with Conserved Regions of HIV-1 in Nairobi, Kenya.
May 2020, Vaccines,
S L Rowland-Jones, and T Dong, and K R Fowke, and J Kimani, and P Krausa, and H Newell, and T Blanchard, and K Ariyoshi, and J Oyugi, and E Ngugi, and J Bwayo, and K S MacDonald, and A J McMichael, and F A Plummer
A vaccine encoding conserved promiscuous HIV CD4 epitopes induces broad T cell responses in mice transgenic to multiple common HLA class II molecules.
June 2010, PloS one,
S L Rowland-Jones, and T Dong, and K R Fowke, and J Kimani, and P Krausa, and H Newell, and T Blanchard, and K Ariyoshi, and J Oyugi, and E Ngugi, and J Bwayo, and K S MacDonald, and A J McMichael, and F A Plummer
[Immunodominance in CD8+ T cell responses to HIV-1 synthesized epitopes].
September 2007, Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology,
S L Rowland-Jones, and T Dong, and K R Fowke, and J Kimani, and P Krausa, and H Newell, and T Blanchard, and K Ariyoshi, and J Oyugi, and E Ngugi, and J Bwayo, and K S MacDonald, and A J McMichael, and F A Plummer
HIV-1-specific cytotoxic T-cell responses.
January 1995, AIDS (London, England),
S L Rowland-Jones, and T Dong, and K R Fowke, and J Kimani, and P Krausa, and H Newell, and T Blanchard, and K Ariyoshi, and J Oyugi, and E Ngugi, and J Bwayo, and K S MacDonald, and A J McMichael, and F A Plummer
HIV infection among lower socioeconomic strata prostitutes in Nairobi.
February 1990, AIDS (London, England),
S L Rowland-Jones, and T Dong, and K R Fowke, and J Kimani, and P Krausa, and H Newell, and T Blanchard, and K Ariyoshi, and J Oyugi, and E Ngugi, and J Bwayo, and K S MacDonald, and A J McMichael, and F A Plummer
HIV epitopes recognized by cytotoxic T-lymphocytes.
January 1991, AIDS (London, England),
Copied contents to your clipboard!